However, it is encouraging that preclinical and early human studies suggest that GLP-1 agonism appears broadly protective: indeed clinical trials of these agents are being initiated in cardiovascular disease (SELECT and SOUL trials, see below), NASH, and neurodegeneration (Alzheimers and Parkinsons)
3,4 Currently, no specific treatment for PCOS exists
Taking off the cap exposes the needle to germs, which could lead to an infection
GHK-Cu 100mg is relevant to laboratory research involving copper peptide activity, peptide-copper binding, extracellular matrix signalling, collagen-related research models, skin biology, wound biology and analytical peptide comparison
However, prior authorizations and approvals can make ongoing access difficult